Companies/Diagonal Bio AB
Follow

Diagonal Bio AB

Nasdaq First North GM Stockholm (Sweden)

Diagonal Bio is developing a diagnostic platform for ultra-rapid, parallel, accurate and cost-efficient detection of any kind of pathogen - Panviral.
Go to market

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Media
Showing 3 of 4
View all
www.diagonalbio.com
Current instruments
Type
Ticker
ISIN
SHARE
DIABIO
SE0015961826
Nasdaq First North GM Stockholm Sweden (SE)
Top
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
DIABIO
SE0015961826
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Diagonal Bio AB with ticker DIABIO
Status
Active
Currency
SEK
First trading date
16 Jul 2021
Rights issue
Sign in to buy
People
Jack Egelund-Madsen
CEO
Eva Nilsagård
Chairman of the board
Kerstin Åkesson Jakobsson
Board member
Edvard Hall
Board member
Kushagr Punyani
Board member
Company Details
Sector
HEALTH CARE
Website
Address
Scheelevägen 8
Zip code
223 81
City/district
Lund
Country
Sweden (SE)
Phones
Email
[email protected]
Registration number
559248-8984
LEI code
9845000469E56665DD98
First trade date
16 Jul 2021
Registration date
19 Mar 2020
Short name
Diagonal

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More